Bitterroot Bio Funding & Investors
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
brbio.comTotal Amount Raised: $145,000,000
Bitterroot Bio Funding Rounds
Series A
$145,000,000
Series A Investors
Arch Venture PartnersDeerfield ManagementGVAlexandria Venture InvestmentsKoch Disruptive Technologies
Funding info provided by Diffbot.